Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249346323> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- W4249346323 endingPage "890" @default.
- W4249346323 startingPage "890" @default.
- W4249346323 abstract "International Journal of Clinical PracticeVolume 60, Issue 7 p. 890-890 Free Access Erratum This article corrects the following: Efficacy, tolerability and safety of darifenacin, an M3 selective receptor antagonist: an investigation of warning time in patients with OAB N. Zinner, J. Susset, M. Gittelman, M. Arguinzoniz, L. Rekeda, F. Haab, Volume 60Issue 1International Journal of Clinical Practice pages: 119-126 First Published online: December 20, 2005 First published: 09 October 2008 https://doi.org/10.1111/j.1742-1241.2006.01055.xCitations: 1AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Efficacy, tolerability and safety of darifenacin, an M3 selective receptor antagonist: an investigation of warning time in patients with OAB. Int J Clin Pract 2006; 60: 119–26. Following the publication of the above Original article (1), the authors would like to apologise for four errors made in Table 3. The table has been corrected to read as follows: Table 3. Post-hoc Poisson analysis of three secondary efficacy variables at week 12 Ratio of incidences with darifenacin 15 mg qd vs placebo* 95% CI Percentage reduction with darifenacin 15 mg qd over placebo 95% CI p-value Urge incontinence episodes/week 0.75 0.61, 0.91 25 9, 39 0.0046 Micturitions/24 hours 0.93 0.89, 0.98 7 2, 11 0.0107 Urgency episodes/week 0.93 0.88, 0.98 7 2, 12 0.0077 *The ratio of incidences <1 implies that darifenacin-treated patients had fewer incidences of incontinence, micturitions and urgency episodes than placebo-treated patients. Reference 1 Zinner N, Susset J, Gittelman M, Arguinzoniz M, Rekeda L, Haab F. Efficacy, tolerability and safety of darifenacin, an M3 selective receptor antagonist: an investigation of warning time in patients with OAB. Int J Clin Pract 2006; 60: 119– 26. Citing Literature Volume60, Issue7July 2006Pages 890-890 ReferencesRelatedInformation" @default.
- W4249346323 created "2022-05-12" @default.
- W4249346323 date "2008-10-09" @default.
- W4249346323 modified "2023-10-14" @default.
- W4249346323 title "Erratum" @default.
- W4249346323 cites W1489300958 @default.
- W4249346323 doi "https://doi.org/10.1111/j.1742-1241.2006.01055.x" @default.
- W4249346323 hasPublicationYear "2008" @default.
- W4249346323 type Work @default.
- W4249346323 citedByCount "0" @default.
- W4249346323 crossrefType "journal-article" @default.
- W4249346323 hasConcept C126322002 @default.
- W4249346323 hasConcept C142724271 @default.
- W4249346323 hasConcept C170493617 @default.
- W4249346323 hasConcept C197934379 @default.
- W4249346323 hasConcept C204787440 @default.
- W4249346323 hasConcept C27081682 @default.
- W4249346323 hasConcept C2776885963 @default.
- W4249346323 hasConcept C2778375690 @default.
- W4249346323 hasConcept C71924100 @default.
- W4249346323 hasConceptScore W4249346323C126322002 @default.
- W4249346323 hasConceptScore W4249346323C142724271 @default.
- W4249346323 hasConceptScore W4249346323C170493617 @default.
- W4249346323 hasConceptScore W4249346323C197934379 @default.
- W4249346323 hasConceptScore W4249346323C204787440 @default.
- W4249346323 hasConceptScore W4249346323C27081682 @default.
- W4249346323 hasConceptScore W4249346323C2776885963 @default.
- W4249346323 hasConceptScore W4249346323C2778375690 @default.
- W4249346323 hasConceptScore W4249346323C71924100 @default.
- W4249346323 hasIssue "7" @default.
- W4249346323 hasLocation W42493463231 @default.
- W4249346323 hasOpenAccess W4249346323 @default.
- W4249346323 hasPrimaryLocation W42493463231 @default.
- W4249346323 hasRelatedWork W1966397043 @default.
- W4249346323 hasRelatedWork W202460821 @default.
- W4249346323 hasRelatedWork W2030348591 @default.
- W4249346323 hasRelatedWork W2126066542 @default.
- W4249346323 hasRelatedWork W2148218079 @default.
- W4249346323 hasRelatedWork W2409130183 @default.
- W4249346323 hasRelatedWork W2608678526 @default.
- W4249346323 hasRelatedWork W2727400130 @default.
- W4249346323 hasRelatedWork W2901706913 @default.
- W4249346323 hasRelatedWork W4206925355 @default.
- W4249346323 hasVolume "60" @default.
- W4249346323 isParatext "false" @default.
- W4249346323 isRetracted "false" @default.
- W4249346323 workType "erratum" @default.